Roadside Drug Testing Devices Market By Sample Type, By Substance, By End User: Global Opportunity Analysis and Industry Forecast, 2021-2031

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market

CHAPTER 4: ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Saliva
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market share analysis by country
4.3 Breath
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market share analysis by country
4.4 Others
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market share analysis by country

CHAPTER 5: ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE
5.1 Overview
5.1.1 Market size and forecast
5.2 Drugs
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market share analysis by country
5.3 Alcohol
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market share analysis by country

CHAPTER 6: ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2 Highway Police
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market share analysis by country
6.3 Drug Enforcement Agencies
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market share analysis by country

CHAPTER 7: ROADSIDE DRUG TESTING DEVICES MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Sample Type
7.2.3 North America Market size and forecast, by Substance
7.2.4 North America Market size and forecast, by End User
7.2.5 North America Market size and forecast, by country
7.2.5.1 U. S.
7.2.5.1.1 Key market trends, growth factors and opportunities
7.2.5.1.2 Market size and forecast, by Sample Type
7.2.5.1.3 Market size and forecast, by Substance
7.2.5.1.4 Market size and forecast, by End User
7.2.5.2 Canada
7.2.5.2.1 Key market trends, growth factors and opportunities
7.2.5.2.2 Market size and forecast, by Sample Type
7.2.5.2.3 Market size and forecast, by Substance
7.2.5.2.4 Market size and forecast, by End User
7.2.5.3 Mexico
7.2.5.3.1 Key market trends, growth factors and opportunities
7.2.5.3.2 Market size and forecast, by Sample Type
7.2.5.3.3 Market size and forecast, by Substance
7.2.5.3.4 Market size and forecast, by End User
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Sample Type
7.3.3 Europe Market size and forecast, by Substance
7.3.4 Europe Market size and forecast, by End User
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Key market trends, growth factors and opportunities
7.3.5.1.2 Market size and forecast, by Sample Type
7.3.5.1.3 Market size and forecast, by Substance
7.3.5.1.4 Market size and forecast, by End User
7.3.5.2 France
7.3.5.2.1 Key market trends, growth factors and opportunities
7.3.5.2.2 Market size and forecast, by Sample Type
7.3.5.2.3 Market size and forecast, by Substance
7.3.5.2.4 Market size and forecast, by End User
7.3.5.3 UK
7.3.5.3.1 Key market trends, growth factors and opportunities
7.3.5.3.2 Market size and forecast, by Sample Type
7.3.5.3.3 Market size and forecast, by Substance
7.3.5.3.4 Market size and forecast, by End User
7.3.5.4 Italy
7.3.5.4.1 Key market trends, growth factors and opportunities
7.3.5.4.2 Market size and forecast, by Sample Type
7.3.5.4.3 Market size and forecast, by Substance
7.3.5.4.4 Market size and forecast, by End User
7.3.5.5 Spain
7.3.5.5.1 Key market trends, growth factors and opportunities
7.3.5.5.2 Market size and forecast, by Sample Type
7.3.5.5.3 Market size and forecast, by Substance
7.3.5.5.4 Market size and forecast, by End User
7.3.5.6 Rest of Europe
7.3.5.6.1 Key market trends, growth factors and opportunities
7.3.5.6.2 Market size and forecast, by Sample Type
7.3.5.6.3 Market size and forecast, by Substance
7.3.5.6.4 Market size and forecast, by End User
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Sample Type
7.4.3 Asia-Pacific Market size and forecast, by Substance
7.4.4 Asia-Pacific Market size and forecast, by End User
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 Japan
7.4.5.1.1 Key market trends, growth factors and opportunities
7.4.5.1.2 Market size and forecast, by Sample Type
7.4.5.1.3 Market size and forecast, by Substance
7.4.5.1.4 Market size and forecast, by End User
7.4.5.2 China
7.4.5.2.1 Key market trends, growth factors and opportunities
7.4.5.2.2 Market size and forecast, by Sample Type
7.4.5.2.3 Market size and forecast, by Substance
7.4.5.2.4 Market size and forecast, by End User
7.4.5.3 Australia
7.4.5.3.1 Key market trends, growth factors and opportunities
7.4.5.3.2 Market size and forecast, by Sample Type
7.4.5.3.3 Market size and forecast, by Substance
7.4.5.3.4 Market size and forecast, by End User
7.4.5.4 India
7.4.5.4.1 Key market trends, growth factors and opportunities
7.4.5.4.2 Market size and forecast, by Sample Type
7.4.5.4.3 Market size and forecast, by Substance
7.4.5.4.4 Market size and forecast, by End User
7.4.5.5 South Korea
7.4.5.5.1 Key market trends, growth factors and opportunities
7.4.5.5.2 Market size and forecast, by Sample Type
7.4.5.5.3 Market size and forecast, by Substance
7.4.5.5.4 Market size and forecast, by End User
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Key market trends, growth factors and opportunities
7.4.5.6.2 Market size and forecast, by Sample Type
7.4.5.6.3 Market size and forecast, by Substance
7.4.5.6.4 Market size and forecast, by End User
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Sample Type
7.5.3 LAMEA Market size and forecast, by Substance
7.5.4 LAMEA Market size and forecast, by End User
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Key market trends, growth factors and opportunities
7.5.5.1.2 Market size and forecast, by Sample Type
7.5.5.1.3 Market size and forecast, by Substance
7.5.5.1.4 Market size and forecast, by End User
7.5.5.2 Saudi Arabia
7.5.5.2.1 Key market trends, growth factors and opportunities
7.5.5.2.2 Market size and forecast, by Sample Type
7.5.5.2.3 Market size and forecast, by Substance
7.5.5.2.4 Market size and forecast, by End User
7.5.5.3 South Africa
7.5.5.3.1 Key market trends, growth factors and opportunities
7.5.5.3.2 Market size and forecast, by Sample Type
7.5.5.3.3 Market size and forecast, by Substance
7.5.5.3.4 Market size and forecast, by End User
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Key market trends, growth factors and opportunities
7.5.5.4.2 Market size and forecast, by Sample Type
7.5.5.4.3 Market size and forecast, by Substance
7.5.5.4.4 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Players
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments

CHAPTER 9: COMPANY PROFILES
9.1 Abbott Laboratories
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 AK GlobalTech Corporation
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Alcohol Countermeasure Systems Corp.
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 Cannabix Technologies Inc.
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Dräger
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Intelligent Fingerprinting
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Lifeloc Technologies, Inc.
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Oranoxis Inc.
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Thermo Fisher Scientific, Inc.
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 UriTox LLC.
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments

Executive Summary

According to this report, titled, 'Roadside Drug Testing Devices Market,' the roadside drug testing devices market size was valued at $421.76 million in 2021, and is estimated to reach $707.3 million by 2031, growing at a CAGR of 5.3% from 2022 to 2031.

Roadside drug testing devices are used by highway police or law enforcement to detect drugs and alcohol in a person’s body by analyzing biological samples such as blood, sweat and urine. Roadside drug testing is done with specially designed devices such as breathalyzers, drug wipes, and oral fluids. Breathalyzers are small portable device which has a mouthpiece attached and two chambers containing liquid connected to a meter that detects a change in color. The subject exhales through the mouthpiece into a test chamber filled with a reddish-orange solution of potassium dichromate. A test called the drug wipe is used to check surfaces for any signs of drug residue. Individuals may further be tested using their sweat or saliva. Using the drug wipe, law enforcement officers at the roadside may rapidly check drivers they suspect of being under the influence of drugs.

Alcohol and drugs are detected with the help of breathalyzers, drug wipes, and oral fluids. Breathalyzers are compact, portable devices with a mouthpiece and two liquid-filled chambers, which determine the amount of alcohol in the system of persons suspected of being intoxicated. The subject exhales into a test container that is filled with a liquid potassium dichromate solution that is orange-red. Surfaces are examined for any indications of drug residue using a technique known as the drug wipe. Sweat or saliva tests may also be used on people. Law enforcement authorities may quickly screen drivers they suspect of being under the influence of narcotics using the drug wipe at the roadside.

Factors that drive the roadside drug testing devices market growth include rise in prevalence of roadside traffic accidents. Both developed & developing countries frequently sell roadside drug testing equipment. The market for roadside drug testing devices has a significant development opportunity due to surge in drink-spiking at amusement parties.

Furthermore, sales of roadside drug testing devices have increased with a hike in the use of 3,4-Methyl​enedioxy​methamphetamine, cocaine, cannabis, and amphetamines which is boosting the roadside drug testing devices market trends.

The roadside drug testing devices industry is segmented into sample type, substance type, end user, and region.

On the basis of sample type, the market is divided into saliva, breath, and others which includes blood and urine.

By end user, the market is categorized as highway police and drug enforcement agencies. The highway police segment dominated the market in 2021, and this trend is expected to continue during the forecast period, due to rise in trend of drinking in amusement parties and driving.

North America accounted for a majority of the global roadside drug testing devices market share in 2021, and is anticipated to remain dominant during the forecast period. This is attributed to rise in the prevalence of late-night clubs also, consumption of drugs and alcohol enhance the need for roadside drug testing equipment for drug detection. Further, Asia-Pacific is anticipated to become the second largest in the sales of roadside drug testing devices. The need for roadside drug testing equipment is anticipated to increase due to change in lifestyles and late-night working hours that encourage drinking and driving. In addition, it is predicted that more effective and alert law enforcement will support the region's sales of roadside drug testing equipment.

Key findings of the study

On the basis of sample type, the breath segment was the highest contributor to the market in 2021.

Based on substance type, the alcohol segment was the highest contributor to the market in 2021.

By end user, the highway police segment dominated the market in 2021.

Region wise, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

Companies Mentioned

• Dräger
• Alcohol Countermeasure Systems Corp.
• Ak Globaltech Corporation
• Cannabix Technologies Inc.
• Intelligent Fingerprinting
• Lifeloc Technologies, Inc.
• Oranoxis Inc.
• Thermo Fisher Scientific, Inc.
• Uritox LLC.
• Abbott Laboratories

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

• Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
• Scientific and technical writings for product information and related preemptions
• Regional government and statistical databases for macro analysis
• Authentic news articles and other related releases for market evaluation
• Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.